These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6443609)

  • 21. 32P-postlabeling analysis of DNA adducts in liver of wild English sole (Parophrys vetulus) and winter flounder (Pseudopleuronectes americanus).
    Varanasi U; Reichert WL; Stein JE
    Cancer Res; 1989 Mar; 49(5):1171-7. PubMed ID: 2917348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of DNA base damage by 32P-postlabelling: TLC separation of 5'-deoxynucleoside monophosphates.
    Hollstein M; Nair J; Bartsch H; Bochner B; Ames BN
    IARC Sci Publ; 1986; (70):437-48. PubMed ID: 3793190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 32P-postlabeling analysis of aromatic DNA adducts in fish from polluted areas.
    Dunn BP; Black JJ; Maccubbin A
    Cancer Res; 1987 Dec; 47(24 Pt 1):6543-8. PubMed ID: 3677092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ³²P-postlabelling for the sensitive detection of DNA adducts.
    Jones NJ
    Methods Mol Biol; 2012; 817():183-206. PubMed ID: 22147574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of methods for measuring biological markers of formaldehyde exposure.
    Fennell TR
    Res Rep Health Eff Inst; 1994 Jun; (67):1-20; discussion 21-6. PubMed ID: 7917119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC
    IARC Sci Publ; 1993; (124):11-23. PubMed ID: 8225473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
    Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
    Li D; Wang M; Dhingra K; Hittelman WN
    Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL; Beland FA; Marques MM
    Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of an interlaboratory trial of 32P-postlabelling.
    Phillips DH; Castegnaro M
    IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of DNA alkylphosphotriesters by 32P postlabeling: evidence for the nonrandom manifestation of phosphotriester lesions in vivo.
    Guichard Y; Jones GD; Farmer PB
    Cancer Res; 2000 Mar; 60(5):1276-82. PubMed ID: 10728687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.